Search results
10 hours ago · In the primary (first interim) analysis with data cut-off on 21 May 2021, the primary endpoint was met with median PFS not reached for trastuzumab deruxtecan compared with 6.8 months for trastuzumab emtansine (hazard ratio [HR] 0.28, 95% confidence interval [CI] 0.22–0.37; p < 0.001).
10 hours ago · Under its Economic Transition Scenario, EV sales are set to rise from 13.9 million in 2023 to over 30 million in 2027 while “in the next four years, electric car sales grow at an average of 21% per year, compared to the average of 61% between 2020 and The EV share of global new passenger vehicle sales jumps to 33% in 2027, from 17.8% in 2023.”
